These findings are supported by our in vitro data in which VIP induced a dose dependent decrease in the proliferation of the bladder cancer cell line, and reduced the elaboration of MIF, which is known to increase cancer cell proliferation and angiogenesis (10, 14, 15). The gene discussed is VIP; the disease is urinary bladder cancer.